MicroPort Scientific : ®'s Product Obtained the CFDA Certification

Shanghai, China - Recently, independently researched and developed by Shanghai MicroPort Medical (Group) Co., Ltd. ('MicroPort'), the Disposable Intravascular Catheter Accessories product obtained the official registration certificate issued by China Food and Drug Administration ('CFDA'). This time's registration for the product is a combination of a registration renewal and product change. The Disposable Intravascular Catheter Accessories product is composed of a guidewire, high pressure valve and high pressure connecting pipe, which serves as the auxiliary equipment in angiography and interventional operations. During the market-entry period, the clinical safety and effectiveness of the product has been recognized by peers, medical professional, and patients.

About MicroPort

MicroPort Scientific Corporation (the 'Group') is a leading medical device company with business focusing on innovating, manufacturing, and marketing high-quality and high-end medical devices globally. With a diverse portfolio of products now being used at an average rate of one for every 18 seconds in thousands of major hospitals around the world, the Group maintains world-wide operations in a broad range of business segments including Cardiovascular, Orthopedic, Electrophysiological, Endovascular, Neurovascular, Surgical, Diabetes Care and Endocrinal Management, and others. MicroPort is dedicated to becoming a patient oriented global enterprise improve and reshape patient lives through application of innovative science and technology.

For more information, please refer to: www.microport.com

Forward-Looking Statements

Some information contained on this website contains forward-looking statements. These forward-looking statements include, without limitation, those regarding our future financial position, our strategy, plans, objectives, goals and targets, future developments in the markets where we participate or are seeking to participate, and any statements preceded by, followed by or that include the words 'believe', 'intend', 'expect', anticipate', 'project', 'estimate', 'predict', 'is confident', 'has confidence' and similar expressions are also intended to identify forward-looking statements. Such statements are based upon the current beliefs and expectations of MicroPort's management and are subject to significant risks and uncertainties. MicroPort Scientific Corporation undertakes no obligation to update any of the statements. These forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties and other factors that could cause actual future results to differ materially from current expectations include, but are not limited to, general industry and economic conditions, PRC governmental policies and regulations relating to the medical device manufacturing industry, competition in the medical device manufacturing industry, our ability to develop new products and stay abreast of market trends and technological advances, our goals and strategies, our ability to execute strategic acquisitions of, investments in or alliances with other companies and businesses, fluctuations in general economic and business conditions in China.

This document is for information purposes only and does not constitute or form part of any offer or invitation to sell or the solicitation of an offer or invitation to purchase or subscribe for any securities of MicroPort Scientific Corporation, and no part of it shall form the basis of, or be relied upon in connection with, any agreement, arrangement, contract, commitment or investment decision in relation thereto whatsoever.

All rights reserved.
Copyright © 2016 MicroPort Scientific Corporation

CONTACT:

Jonathan Chen Senior Vice President, International Operations and Investor Relations MicroPort Scientific Corporation Tel: [phone] Email: [e-mail]

Priscilla Li Manager of Shareholders and Security Affairs Shanghai MicroPort Medical (Group) Co., Ltd. (HQ) Tel: [phone]-6958 Email: [e-mail]